| Sources | Names Used |
|---|---|
| CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
| PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MST1R | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-05 |
| mRNA | SOX9 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-05 |
| mRNA | FSTL1 | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-05 |
| mRNA | SPHAR | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | PRY2 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | HAL | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | BAHCC1 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | FAM189A1 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | RNF128 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | RGS12 | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
